Monday, February 26, 2024
BestWooCommerceThemeBuilttoBoostSales-728x90

Analysis of clinicopathologic and imaging features of dual-phenotype hepatocellular carcinoma – Scientific Reports


  • Yang, J. D. & Roberts, L. R. Hepatocellular carcinoma: A global view. Nat. Rev. Gastroenterol. Hepatol. 7(8), 448–458 (2010).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sayiner, M., Golabi, P. & Younossi, Z. M. Disease burden of hepatocellular carcinoma: A global perspective. Dig. Dis. Sci. 64(4), 910–917 (2019).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J. Clin. 65(2), 87–108 (2015).

    Article 
    PubMed 

    Google Scholar
     

  • Fléjou, J. F. WHO Classification of digestive tumors: The fourth edition. Ann. Pathol. 31(5 Suppl), S27-31 (2011).

    Article 
    PubMed 

    Google Scholar
     

  • Paradis, V. Histopathology of hepatocellular carcinoma. Recent Results Cancer Res. 190, 21–32 (2013).

    Article 
    PubMed 

    Google Scholar
     

  • El-Serag, H. B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142(6), 1264-1273.e1 (2012).

    Article 
    PubMed 

    Google Scholar
     

  • Ford, M. M. et al. Geographic epidemiology of hepatocellular carcinoma, viral hepatitis, and socioeconomic position in New York City. Cancer Causes Control 28(7), 779–789 (2017).

    Article 
    PubMed 

    Google Scholar
     

  • Mittal, S. & El-Serag, H. B. Epidemiology of hepatocellular carcinoma: Consider the population. J. Clin. Gastroenterol. 47, S2-6 (2013).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • El-Serag, H. B. & Rudolph, K. L. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology. 132(7), 2557–2576 (2007).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Liu, Y. & Wu, F. Global burden of aflatoxin-induced hepatocellular carcinoma: A risk assessment. Environ. Health Perspect. 118(6), 818–824 (2010).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gluer, A. M. et al. Systematic review of actual 10-year survival following resection for hepatocellular carcinoma. HPB (Oxford) 14(5), 285–290 (2012).

    Article 
    PubMed 

    Google Scholar
     

  • Zhong, J. et al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann. Surg. 260(2), 329–40 (2014).

    Article 
    PubMed 

    Google Scholar
     

  • Halazun, K. J. et al. Recurrence after liver transplantation for hepatocellular carcinoma: A new MORAL to the story. Ann. Surg. 265(3), 557–564 (2017).

    Article 
    PubMed 

    Google Scholar
     

  • Neeff, H. et al. Hepatic resection for hepatocellular carcinoma–results and analysis of the current literature. Zentralbl Chir. 134(2), 127–135 (2009).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ma, W., Wang, H. & Teng, L. Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy. World J. Surg. Oncol. 11, 212 (2013).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shim, J. H. et al. Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis. Ann. Surg. Oncol. 19(12), 3687–3696 (2012).

    Article 
    PubMed 

    Google Scholar
     

  • Yao, Q. et al. Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma. Medicine (Baltimore) 96(17), e6735 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Nathan, H., Schulick, R. D., Choti, M. A. & Pawlik, T. M. Predictors of survival after resection of early hepatocellular carcinoma. Ann. Surg. 249(5), 799–805 (2009).

    Article 
    PubMed 

    Google Scholar
     

  • Zhu, Q. et al. Prognostic factors for survival after hepatic resection of early hepatocellular carcinoma in HBV-related cirrhotic patients. Clin. Res. Hepatol. Gastroenterol. 40(4), 418–427 (2016).

    Article 
    PubMed 

    Google Scholar
     

  • Sakamoto, K. & Nagano, H. Surgical treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus. Hepatol. Res. 47(10), 957–962 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Vitale, A. et al. Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study. J. Hepatol. 62(3), 617–624 (2015).

    Article 
    PubMed 

    Google Scholar
     

  • Najjar, M., Agrawal, S., Emond, J. C. & Halazun, K. J. Pretreatment neutrophil-lymphocyte ratio: Useful prognostic biomarker in hepatocellular carcinoma. J. Hepatocell Carcinoma 5, 17–28 (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sena, G. et al. Surgical resection of a recurrent hepatocellular carcinoma with portal vein thrombosis: Is it a good treatment option? A case report and systematic review of the literature. J. Clin. Med. 11(18), 5287 (2022).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sun, M. et al. Expression profile reveals novel prognostic biomarkers in hepatocellular carcinoma. Front. Biosci. (Elite Ed.) 2(3), 829–840 (2010).

    PubMed 

    Google Scholar
     

  • Yang, X. R. et al. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma. Gut 59(7), 953–962 (2010).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Lu, X. Y. et al. Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior. Ann. Surg. Oncol. 18(8), 2210–2217 (2011).

    Article 
    PubMed 

    Google Scholar
     

  • Cong, W. M. et al. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update. World J. Gastroenterol. 22(42), 9279–9287 (2016).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Durnez, A. et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 49(2), 138–151 (2006).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Nishihara, Y. et al. Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization. J. Gastroenterol. Hepatol. 23(12), 1860–1868 (2008).

    Article 
    PubMed 

    Google Scholar
     

  • Lai, J. P., Conley, A., Knudsen, B. S. & Guindi, M. Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinoma. Histopathology 67(4), 442–450 (2015).

    Article 
    PubMed 

    Google Scholar
     

  • Choi, W. T. & Kakar, S. Immunohistochemistry in the diagnosis of hepatocellular carcinoma. Gastroenterol. Clin. North Am. 46(2), 311–325 (2017).

    Article 
    PubMed 

    Google Scholar
     

  • Chung, G. E. et al. Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma. Abdom. Imaging 37(3), 439–446 (2012).

    Article 
    PubMed 

    Google Scholar
     

  • Govaere, O. et al. Keratin 19: A key role player in the invasion of human hepatocellular carcinomas. Gut 63(4), 674–685 (2014).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Bae, J. S. et al. Expression of K19 and K7 in dysplastic nodules and hepatocellular carcinoma. Oncol. Lett. 4(2), 213–220 (2012).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kim, C. K. et al. Neoangiogenesis and sinusoidal capillarization in hepatocellular carcinoma: Correlation between dynamic CT and density of tumor microvessels. Radiology. 237(2), 529–534 (2005).

    Article 
    PubMed 

    Google Scholar
     

  • Bolondi, L. et al. Characterization of small nodules in cirrhosis by assessment of vascularity: The problem of hypovascular hepatocellular carcinoma. Hepatology 42(1), 27–34 (2005).

    Article 
    PubMed 

    Google Scholar
     

  • Takayasu, K., Muramatsu, Y., Mizuguchi, Y. & Ojima, H. CT Imaging of early hepatocellular carcinoma and the natural outcome of hypoattenuating nodular lesions in chronic liver disease. Oncology 72(Suppl 1), 83–91 (2007).

    Article 
    PubMed 

    Google Scholar
     

  • Yoon, S. H. et al. Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: Tumor size and cellular differentiation. AJR Am. J. Roentgenol. 193(6), W482-489 (2009).

    Article 
    PubMed 

    Google Scholar
     

  • Ayuso, C. et al. Diagnosis and staging of hepatocellular carcinoma (HCC): Current guidelines. Eur. J. Radiol. 101, 72–81 (2018).

    Article 
    PubMed 

    Google Scholar
     

  • van Eyken, P., Sciot, R., van Damme, B., de Wolf-Peeters, C. & Desmet, V. J. Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient. Virchows Arch. A Pathol. Anat. Histopathol. 412(1), 63–72 (1987).

    Article 
    PubMed 

    Google Scholar
     

  • Bateman, A. C. & Hübscher, S. G. Cytokeratin expression as an aid to diagnosis in medical liver biopsies. Histopathology 56(4), 415–425 (2010).

    Article 
    PubMed 

    Google Scholar
     

  • van Sprundel, R. G. H. M. et al. Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours. Comp. Hepatol. 9(1), 4 (2010).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Imamura, H. et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J. Hepatol. 38(2), 200–207 (2003).

    Article 
    PubMed 

    Google Scholar
     

  • Wang, Z. et al. CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy. Zhonghua Zhong Liu Za Zhi 34(10), 753–8 (2012).

    CAS 
    PubMed 

    Google Scholar
     

  • Sun, D. et al. Prognostic value of cytokeratin 19 in hepatocellular carcinoma: A meta-analysis. Clin. Chim. Acta 448, 161–9 (2015).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • van Sprundel, R. G. et al. Cellular characteristics of keratin 19-positive canine hepatocellular tumours explain its aggressive behaviour. Vet. Rec. Open 4(1), e000212 (2017).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Au, K. Y., Chan, K. K. S. & Lo, R. C. L. A Clinicopathological Study of Young-onset Hepatocellular Carcinoma. Anticancer Res. 41(6), 2933–2944 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Klein, W. M. et al. Primary liver carcinoma arising in people younger than 30 years. Am. J. Clin. Pathol. 124(4), 512–518 (2005).

    Article 
    PubMed 

    Google Scholar
     



  • Source link

    Related Articles

    Leave a Reply

    [td_block_social_counter facebook="beingmedicos1" twitter="being_medicos" youtube="beingmedicosgroup" style="style8 td-social-boxed td-social-font-icons" tdc_css="eyJhbGwiOnsibWFyZ2luLWJvdHRvbSI6IjM4IiwiZGlzcGxheSI6IiJ9LCJwb3J0cmFpdCI6eyJtYXJnaW4tYm90dG9tIjoiMzAiLCJkaXNwbGF5IjoiIn0sInBvcnRyYWl0X21heF93aWR0aCI6MTAxOCwicG9ydHJhaXRfbWluX3dpZHRoIjo3Njh9" custom_title="Stay Connected" block_template_id="td_block_template_8" f_header_font_family="712" f_header_font_transform="uppercase" f_header_font_weight="500" f_header_font_size="17" border_color="#dd3333"]
    - Advertisement -spot_img

    Latest Articles